MORE►
Cx Precision Medicine
Left: Sid O’Bryant, PhD, Scientific Founder and Advisory Board Chair at CxPM; Right: CxPM CEO Danguole Altman [Photos: CxPM]
HSC Spinout CxPM Joins StartUp Health’s Alzheimer’s Moonshot Community
by David Seeley | Oct 24, 2024
"I embarked on this journey of creating a blood test for Alzheimer’s detection in primary care because of my own clinical and personal experiences," said UNT HSC's Dr. Sid O’Bryant, founder of Cx Precision Medicine. Now, by joining the Moonshot community, CxPM has gained "invaluable access to a network of investors, collaborators, and strategic partners" that could help drive its mission forward.
by David Seeley |
Oct 6, 2023
TechFW's Impact Showcase "embodied the spirit of innovation, the essence of progress, and the promise of a better tomorrow" at Dickies Arena's
Simmons Bank Pavilion Thursday in Fort Worth.
MORE►
by Quincy Preston |
Sep 14, 2023
The North Texas bioscience organization, a driving force for growth in the regional ecosystem, will convene leaders at its flagship conference to catalyze industry opportunities, spotlight emerging companies, and make connections.
See who made this year's Rising Stars list—and how you can attend the summit.
See who made this year's Rising Stars list—and how you can attend the summit.
MORE►
by Sandra Engelland |
Mar 16, 2021
Contracting Alzheimer's is the No. 1 fear of people over 65, says Sid O'Bryant, who wants to give primary physicians the ability to test for Alzheimer's with a blood test. That can offer peace of mind to many and earlier help for those who need it.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
His groundbreaking research, which has revealed significant differences in biomarkers for the disease, could make the treatment of Alzheimer's more like that for cancer—a multi-dimensional "precision" approach.
MORE►
